OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
3.160
-0.180 (-5.39%)
At close: May 15, 2026, 4:00 PM EDT
3.150
-0.010 (-0.32%)
After-hours: May 15, 2026, 5:57 PM EDT
OnKure Therapeutics Employees
OnKure Therapeutics had 45 employees as of December 31, 2025. The number of employees decreased by 1 or -2.17% compared to the previous year.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.17%
Revenue / Employee
n/a
Profits / Employee
-$1,305,533
Market Cap
127.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -1 | -2.17% |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Jun 30, 2024 | 50 | - | - |
| Mar 31, 2024 | 49 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Molecular Partners AG | 134 |
| Alps Group | 93 |
| Agenus | 81 |
| Connect Biopharma Holdings | 64 |
| Aardvark Therapeutics | 40 |
| Equillium | 35 |
| Genelux | 26 |
OKUR News
- 8 days ago - OnKure Therapeutics downgraded to Hold from Buy at JonesResearch - TheFly
- 10 days ago - OnKure Therapeutics Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 21 days ago - OnKure Therapeutics files to sell 36.14M shares of Class A common for holders - TheFly
- 7 weeks ago - OnKure Therapeutics to sell 26.713M shares at $4.15 in private placement - TheFly
- 7 weeks ago - OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies - GlobeNewsWire
- 2 months ago - OnKure Therapeutics price target lowered to $27 from $34 at H.C. Wainwright - TheFly
- 2 months ago - OnKure Therapeutics reports Q4 EPS (99c), consensus ($1.15) - TheFly
- 2 months ago - OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire